Patents by Inventor Lise GRAVELLE

Lise GRAVELLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230063538
    Abstract: A process for preparing a compound of formula (I) wherein the process is suitable for large scale synthesis. The process includes the consecutive steps of a) reacting a compound of formula IX and a catalyst and optionally adding a base in an organic solvent and optional adding a basic fluoride source agent under suitable conditions to obtain a compound of formula X and b) removing the protective groups of the compound X to obtain the compound formula (I).
    Type: Application
    Filed: December 16, 2020
    Publication date: March 2, 2023
    Applicant: GALECTO BIOTECH AB
    Inventors: Lise GRAVELLE, Fredrik ZETTERBERG, Andrew TYRRELL, Christine KINNAERT, Alexander WEYMOUTH-WILSON, Robert CLARKSON
  • Publication number: 20220064204
    Abstract: A stabilized amorphous form of a compound of formula I as well as compositions for oral administration including the compound of formula I in a therapeutically effective amount. Also, methods for treatment of a disease or disorder in which therapeutically effective amount of a composition including a compound of formula I is administered to a subject in need thereof.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 3, 2022
    Applicant: GALECTO BIOTECH AB
    Inventors: Lise GRAVELLE, Peter TIMMINS, Anders PEDERSEN
  • Patent number: 10799482
    Abstract: A process for preparing an amorphous form of a compound of formula (I) This amorphous compound I is particularly suitable in treating IPF by pulmonary administration.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: October 13, 2020
    Assignee: GALECTO BIOTECH AB
    Inventors: Lise Gravelle, Anders Pedersen
  • Publication number: 20190298697
    Abstract: A process for preparing an amorphous form of a compound of formula (I) This amorphous compound I is particularly suitable in treating IPF by pulmonary administration.
    Type: Application
    Filed: May 13, 2019
    Publication date: October 3, 2019
    Applicant: GALECTO BIOTECH AB
    Inventors: Lise GRAVELLE, Anders PEDERSEN
  • Patent number: 10369136
    Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: August 6, 2019
    Assignee: GALECTO BIOTECH AB
    Inventors: Lise Gravelle, Anders Pedersen
  • Patent number: 10307403
    Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: June 4, 2019
    Assignee: GALECTO BIOTECH AB
    Inventors: Lise Gravelle, Anders Pedersen
  • Publication number: 20190117627
    Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.
    Type: Application
    Filed: November 28, 2018
    Publication date: April 25, 2019
    Applicant: GALECTO BIOTECH AB
    Inventors: Lise GRAVELLE, Anders PEDERSEN
  • Publication number: 20180369208
    Abstract: The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.
    Type: Application
    Filed: December 16, 2016
    Publication date: December 27, 2018
    Applicant: GALECTO BIOTECH AB
    Inventors: Lise GRAVELLE, Anders PEDERSEN